Farnesol as antibiotics adjuvant in staphylococcus epidermidis control in vitro

American Journal of the Medical Sciences

Volumn 341, Issue 3, 2011, Pages 191-195

  Gomes, Fernanda ^a   Leite, Bruna ^b   Teixeira, Pilar ^a   Cerca, Nuno ^a   Azeredo, Joana ^a   Oliveira, Rosário ^a  

^a UNIVERSITY OF MINHO   (Portugal)

^b FEDERAL UNIVERSITY OF SÃO CARLOS   (Brazil)

Author keywords

Antibiotics; Biofilm; Farnesol; Planktonic cells; Staphylococcus epidermidis

Indexed keywords

FARNESOL; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN;

ADJUVANT THERAPY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL CELL; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BIOFILM; CELL VIABILITY; COLONY FORMING UNIT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; IN VITRO STUDY; INFECTION CONTROL; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 79952069898     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3181fcf138     Document Type: Article

References (16)

1. Cerca N, Pier GB, Oliveira R, et al. Comparative evaluation of coagulase-negative staphylococci (CoNS) adherence to acrylic by a static method and a parallel-plate flow dynamic method. Res Microbiol 2004;155:755-60. (Pubitemid 39389132)
2. Vuong C, Gerke C, Somerville GA, et al. Quorum-sensing control of biofilm factors in Staphylococcus epidermidis. J Infect Dis 2003;188: 706-18. (Pubitemid 37115184)
3. Ziebuhr W, Hennig S, Eckart M, et al. Nosocomial infections by Staphylococcus epidermidis: how a commensal bacterium turns into a pathogen. Int J Antimicrob Agents 2006;28:14-20. (Pubitemid 44163162)
4. Adam B, Baillie GS, Douglas LJ. Mixed species biofilms of Candida albicans and Staphylococcus epidermidis. J Med Microbiol 2002;51:344-9. (Pubitemid 34252657)
5. Cerca N, Martins S, Cerca F, et al. Comparative assessment of antibiotic susceptibility of coagulase-negative staphylococci in biofilm versus planktonic culture as assessed by bacterial enumeration or rapid XTT colorimetry. J Antimicrob Chemother 2005;56:331-6. (Pubitemid 41158521)
6. Vuong C, Kocianova S, Yao Y, et al. Increased colonization of indwelling medical devices by quorum-sensing mutants of Staphylococcus epidermidis in vivo. J Infect Dis 2004;190:1498-505. (Pubitemid 39332191)
7. Cerca N, Jefferson KK, Oliveira R, et al. Comparative antibodymediated phagocytosis of Staphylococcus epidermidis cells grown in a biofilm or in the planktonic state. Infect Immun 2006;74:4849-55. (Pubitemid 44157272)
8. Oliveira M, Nunes SF, Carneiro C, et al. Time course of biofilm formation by Staphylococcus aureus and Staphylococcus epidermidis mastitis isolates. Vet Microbiol 2007;124:187-91. (Pubitemid 47225007)
9. Jabra-Rizk MA, Meiller TF, James CE, et al. Effect of farnesol on Staphylococcus aureus biofilm formation and antimicrobial susceptibility. Antimicrob Agents Chemother 2006;50:1463-9.
10. Gomes FIA, Teixeira P, Azeredo J, et al. Effect of farnesol on planktonic and biofilm cells of Staphylococcus epidermidis. Curr Microbiol 2009;59:118-22.
11. Cerca N, Pier GB, Vilanova M, et al. Quantitative analysis of adhesion and biofilm formation on hydrophilic and hydrophobic surfaces of clinical isolates of Staphylococcus epidermidis. Res Microbiol 2005b;156:506-14. (Pubitemid 40615418)
12. Aldridge KE. Comparison of the post-antibiotic effect (PAE) induced by ceftizoxime, ceftriaxone, cefoxitin, ampicillin-sulbactam, and ticarcillin- clavulanate against selected isolates of Bacteroides fragilis and B. thetaiotaomicron. Anaerobe 2002;8:295-9. (Pubitemid 36506508)
13. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically-Fifth Edition: Approved Standard M7-A5. Wayne, PA: NCCLS; 1997.
14. Suller MTE, Lloyd D. Flow cytometric assessment of the postantibiotic effect of methicillin on Staphylococcus aureus. Antimicrob Agents Chemother 1998;42:1195-9. (Pubitemid 28227919)
15. Nagl M, Hengster P, Semenitz E, et al. The postantibiotic effect of N-chlorotaurine on Staphylococcus aureus. Application in the mouse peritonitis model. J Antimicrob Chemother 1999;43:805-9. (Pubitemid 29273730)
16. Navarathna DH, Hornby JM, Krishnan N, et al. Effect of farnesol on a mouse model of systemic candidiasis, determined by use of a DPP3 knockout mutant of Candida albicans. Infect Immun 2007; 75:1609-18. (Pubitemid 46559424)